Pfizer Notified Biden Before Trump on Vaccine Success

In an interview with WMAL radio show Wednesday morning, Health and Human Services Secretary Alex Azar appeared to confirm that the Trump administration learned of Pfizer’s successful COVID-19 vaccine trial from press coverage not from company officials directly. “I…learned of this from media reports on Monday morning,” Azar told “Mornings on the Mall” program on November 11. “There certainly was a gap in communications, let’s say.”

Azar, whose agency is a lead government partner in Operation Warp Speed, the president’s ambitious program to manufacture and distribute 300 million COVID-19 vaccine doses by early next year, found out about Pfizer’s results after Joe Biden was notified. “Last night, my public health advisors were informed of this excellent news,” Team Biden said in a statement Monday morning. “I congratulate the brilliant women and men who helped produce this breakthrough and to give us such cause for hope.” The press-ordained president-elect who is promising to unite Americans, however, did not credit the current president or his administration for their efforts.

President Trump is expressing (justified) outrage that Pfizer slow-walked news about their Phase 3 trial until after Election Day. “As I have long said, @Pfizer and the others would only announce a Vaccine after the Election, because they didn’t have the courage to do it before,” Trump tweeted November 9. “Likewise, the @US_FDA should have announced it earlier, not for political purposes, but for saving lives!”

Pfizer, after discussion with the FDA sometime in October, “elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases,” the company disclosed this week. (It’s worth noting that Dr. Scott Gottlieb, a frequent cable news guest and op-ed columnist who uses his platform to stoke unnecessary fear about COVID-19, is the former head of the FDA and a Pfizer board member.)

A separate news article reported that Pfizer’s lab placed test samples in “storage” and resumed testing last Wednesday—the day after Election Day.  “It also means that if Pfizer had held to the original plan, the data would likely have been available in October,” an industry journal confirmed after Pfizer’s official announcement.

The pharmaceutical company, whose employees donated four times as much to Joe Biden than to Donald Trump, also attempted to distance itself from Operation Warp Speed in early press reports. A spokeswoman had to clarify comments made by Pfizer’s head of vaccine development to the New York Times that the company “was never a part of Warp Speed.”

On the same day Pfizer announced its successful vaccine trial, CEO Albert Bourla sold 60 percent of his personal stock at $41.94 per share for a total of $5.6 million; the company’s stock hit a one-year high of $41.99 per share shortly after the news broke Monday.

 

About Julie Kelly

Julie Kelly is a political commentator and senior contributor to American Greatness. She is the author of Disloyal Opposition: How the NeverTrump Right Tried―And Failed―To Take Down the President Her past work can be found at The Federalist and National Review. She also has been featured in the Wall Street Journal, The Hill, Chicago Tribune, Forbes, and Genetic Literacy Project. After college graduation, she served as a policy and communications consultant for several Republican candidates and elected officials in suburban Chicago. She also volunteered for her local GOP organization. After staying home for more than 10 years to raise her two daughters, Julie began teaching cooking classes out of her home. She then started writing about food policy, agriculture, and biotechnology, as well as climate change and other scientific issues. She graduated from Eastern Illinois University in 1990 with a degree in communications and minor degrees in political science and journalism. Julie lives in suburban Chicago with her husband, two daughters, and (unfortunately) three dogs.

Photo: (Photo by Astrid Riecken For The Washington Post via Getty Images)

Want news updates?

Sign up for our newsletter to stay up to date.